Oxycodone/naltrexone: Pivotal trial started

Elite began an open-label, crossover pivotal trial to compare single doses of 40 mg ELI-201 controlled-release capsules vs. 40 mg OxyContin oxycodone controlled-release tablets in healthy volunteers....